Recently in breast cancer, some naturally occurring alternative transcripts of BRCA1 and BRCA2, through mutational variants in the splicing sites, have been found to encode protein isoforms with residual tumor suppressive activity [13]. This evidence concerns the gene BRCA2 and breast cancer.